Back to search
FDAFDA · Food and drugs·Recall number Z-1073-2014

NxStage PureFlow-B Solution; Model/Catalog Number: RFP-401. Product is packaged in a case containing two individual 5L bags. The NxStage PureFlow-B Solution is indicated for use with renal replacement therapy systems that utilize sterile premixed dialysate during hemodialysis.

Published March 5, 2014 · Recall initiated: January 24, 2014

Summary

FDA records medical device Class II recall Z-1073-2014, published March 5, 2014 and initiated January 24, 2014. Recalling firm: NxStage Medical, Inc.; Status: Terminated; Reported quantity: 969 cases (2 bags per case); Lot: Lot Number: F113662. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Mislabeled product.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
NxStage Medical, Inc.
Distributor
US Distribution including the states of NY, TX, ID, AR, CA and AL
Lot
Lot Number: F113662
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was NxStage PureFlow-B Solution; Model/Catalog Number: RFP-401. Product is packaged in a case containing two individual 5L bags. The NxStage PureFlow-B Solution is indicated for use with renal replacement therapy systems that utilize sterile premixed dialysate during hemodialysis. recalled?

Yes. FDA published recall Z-1073-2014 on March 5, 2014. Reported hazard: Mislabeled product.

What should I do if I have this product?

Voluntary: Firm initiated · Letter